SLC5A5 and triple-negative breast carcinoma: Further, the sodium iodide symporter (NIS) has been proposed as a non-immunogenic radionuclide reporter in ErbB T1E28z CAR therapy in two models of triple-negative breast cancer (MDA-MB-231 and MDA-MB-436).